---
title: "Nuvation Bio CSO Gary Hattersley disposes of Class A common shares worth $709,240"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296652019.md"
description: "Nuvation Bio CSO Gary Hattersley exercised options for 100,000 Class A common shares at $1.87 and sold them the same day at a weighted-average price of $7.09 on Aug. 19, 2026. The transaction was valued at approximately $709,240. Following these sales, Hattersley's direct holdings dropped to zero, though he retains beneficial ownership of 400,000 stock options."
datetime: "2026-08-21T20:50:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296652019.md)
  - [en](https://longbridge.com/en/news/296652019.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296652019.md)
generator: "portal-rs"
---

# Nuvation Bio CSO Gary Hattersley disposes of Class A common shares worth $709,240

-   Nuvation Bio Chief Scientific Officer Gary Hattersley exercised stock options for 100,000 Class A common shares on Aug. 19, 2026 at $1.87. \* He sold 100,000 Class A common shares the same day at a weighted-average price of $7.09. \* His direct holdings in Class A common stock fell to 0 shares following the transactions. \* Hattersley reported 400,000 stock options beneficially owned after the exercise. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvation Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001521111-26-000005), on August 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [NUVB.US](https://longbridge.com/en/quote/NUVB.US.md)
- [NUVB+.US](https://longbridge.com/en/quote/NUVB+.US.md)

## Related News & Research

- [Nuvation Bio (NUVB) Gains Fast Track Backing As Fair Value Stays In Focus](https://longbridge.com/en/news/296701962.md)
- [Nuvation Bio Q2 FY26 revenue more than doubled to $31.69 million](https://longbridge.com/en/news/295094076.md)
- [Fluidra buys back 259,500 shares Aug 18-21 at average price 19.15](https://longbridge.com/en/news/296870067.md)
- [Fleury board holding increases by R$ 70,053.75 after on-market share buy](https://longbridge.com/en/news/296728002.md)
- [Agilysys Insiders Sold Shares Worth Over $1.6M](https://longbridge.com/en/news/296401909.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**